List of articles with "AbbVie"

Brise and AbbVie Collaboration

2026-11-02 14:57:14

China Shanghai AbbVie migraine therapies Brise Pharmaceuticals

AbbVie Q3 Financial Report

2026-10-30 12:03:29

USA AbbVie North Chicago Skyrizi RINVOQ

BLA Submission for Etentamig

2026-10-27 12:14:01

United States Multiple Myeloma AbbVie North Chicago Etentamig

SKYRIZI Approval

2026-10-23 19:36:12

USA Crohn's Disease AbbVie North Chicago Skyrizi

AbbVie Launches RINVOQ

2026-10-23 01:10:15

Japan Tokyo AbbVie RINVOQ Juvenile Arthritis

Hidradenitis Suppurativa Breakthrough

2026-10-22 14:03:58

United States AbbVie North Chicago Hidradenitis Lutikizumab

Cancer Breakthrough

2026-10-20 05:31:38

USA AbbVie North Chicago DLBCL Genmab

ABBV-466 Promises

2026-10-19 08:09:42

USA Crohn's Disease AbbVie North Chicago ABBV-466

AbbVie at ESMO 2026

2026-10-18 22:26:33

United States oncology AbbVie North Chicago ESMO 2026

AbbVie IBD Efficacy Insights

2026-10-17 06:08:13

USA AbbVie North Chicago Skyrizi RINVOQ

AbbVie SKYRIZI Results

2026-10-13 19:21:48

USA Crohn's Disease AbbVie North Chicago Skyrizi

AbbVie XEN45 Approved

2026-10-13 06:13:40

Japan AbbVie glaucoma Minato XEN45

Fortune 100 Ranking 2026

2026-10-08 06:10:35

London United Kingdom AbbVie FORTUNE 100 Hilton Worldwide

FDA Breakthrough Designations

2026-10-07 13:13:27

United States AbbVie North Chicago Telisotuzumab Temab-A

Parkinson's Market Growth

2026-10-06 15:33:06

None Parkinson's Disease AbbVie JUVMO

AbbVie EMA Approval

2026-10-06 05:59:28

United States Crohn's Disease AbbVie North Chicago Risankizumab

AbbVie Innovation Award

2026-10-06 02:31:21

Japan Tokyo AbbVie BioLabs Tuning Fork Bio

Epcoritamab Study Success

2026-10-05 18:58:35

USA Epcoritamab AbbVie North Chicago DLBCL

RINVOQ® and Vitiligo Insights

2026-10-01 14:28:16

USA AbbVie North Chicago RINVOQ Vitiligo

AbbVie atogepant results

2026-10-01 04:28:26

United States AbbVie North Chicago Atogepant menstrual migraine

AbbVie Phase 1 Results

2026-09-30 09:50:13

United States AbbVie North Chicago ABBV-295 EASD 2026

AbbVie’s Zumilokibart Results

2026-09-30 05:37:19

United States AbbVie North Chicago Zumilokibart EADV

AbbVie at EADV 2026

2026-09-30 05:06:37

United States dermatology AbbVie North Chicago EADV2026

AbbVie Upadacitinib HS

2026-09-29 04:19:13

Japan AbbVie Minato-ku Hidradenitis Suppurativa Upadacitinib

Entenamig Trial Success

2026-09-28 04:29:29

United States AbbVie North Chicago Entenamig CERVINO

RINVOQ Approval in EU

2026-09-22 06:14:10

None AbbVie RINVOQ Juvenile Arthritis

AbbVie & Iambic Team Up

2026-09-21 12:16:53

United States AI Technology AbbVie North Chicago Iambic

VRAYLAR Presentation

2026-09-18 12:35:54

United States New Orleans AbbVie Psych Congress VRAYLAR

AbbVie Presents Etentamig Data

2026-09-17 12:39:08

USA AbbVie North Chicago Myeloma Etentamig

Pediatric Skyrizi Approval

2026-09-16 05:53:00

Japan Tokyo Psoriasis AbbVie Skyrizi

Epcoritamab Approval

2026-09-16 05:52:50

Japan Follicular Lymphoma Epcoritamab AbbVie Minato-ku, Tokyo

AbbVie and PGA TOUR Unite

2026-09-15 12:53:23

USA AbbVie North Chicago PGA Tour Birdies for Brain Health

AbbVie Quarterly Dividend

2026-09-10 18:24:22

United States Dividend Stockholders AbbVie North Chicago

Vitiligo Treatment in Japan

2026-09-07 01:21:36

Japan Tokyo AbbVie Vitiligo

Etentamig Shows Promise

2026-09-03 13:39:37

United States Multiple Myeloma AbbVie North Chicago Etentamig

AbbVie Acquires Apogee

2026-09-03 12:39:51

United States AbbVie North Chicago Immunology Apogee Therapeutics

Layered Beauty Report

2026-09-02 12:16:12

United States AbbVie North Chicago Allergan Aesthetics Layered Beauty

Barrier Calming Cream

2026-09-01 12:07:29

United States Irvine AbbVie SkinMedica Barrier Calming Cream

AbbVie Seeks SKYRIZI EMA Approval

2026-08-27 06:10:30

United States Crohn's Disease AbbVie North Chicago Skyrizi

EU Approval for Upadacitinib

2026-08-25 05:26:43

None AbbVie Alopecia Areata Upadacitinib

AbbVie Upadacitinib Approval

2026-08-25 05:26:29

United States AbbVie North Chicago Upadacitinib Vitiligo

AbbVie Rinvoq Approval

2026-08-24 05:52:33

Japan Tokyo AbbVie RINVOQ Polyarticular JIA

AbbVie Lung Cancer Insights

2026-08-21 11:47:47

United States AbbVie North Chicago Lung Cancer WCLC 2026

New HCV Treatment Approved

2026-08-07 03:07:27

None AbbVie Gracaprevir Velpatasvir

Epcoritamab Approval

2026-08-05 01:20:30

United States Epcoritamab AbbVie North Chicago Relapsed Follicular Lymphoma

BOTOX® Expansion

2026-08-04 12:14:58

United States Irvine AbbVie Allergan Aesthetics BOTOX Cosmetic

AbbVie Q2 Report

2026-07-31 11:51:15

United States AbbVie North Chicago Skyrizi RINVOQ

RINVOQ® Approval in EU

2026-07-29 07:07:34

None AbbVie Alopecia Areata RINVOQ

AbbVie Approval for Vitiligo

2026-07-29 07:05:30

None AbbVie RINVOQ Vitiligo

Resankizumab FDA Approval

2026-07-22 04:31:43

United States AbbVie North Chicago Pediatrics Resankizumab